LETROZOLE;VRIBOCICLIB SUCCINATE (letrozole; ribociclib succinate) by Msn Labs Pvt Ltd is estrogens. Approved for advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy [see clinical studies (.
Drug data last refreshed 13h ago
estrogens. Treatment of breast cancer thought to be hormonally responsive (i.e., estrogen and/or progesterone receptor positive or receptor unknown) has included a variety of efforts to decrease estrogen levels (ovariectomy, adrenalectomy, hypophysectomy) or inhibit estrogen effects (antiestrogens…
Worked on LETROZOLE;VRIBOCICLIB SUCCINATE at Msn Labs Pvt Ltd? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.